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Summary. One of the most frequent accompanying pathologies during pregnancy – digestive tract 
diseases. The work purpose - to analyse the choice of medicinal therapy among doctors at heartburn 
and constipation treatment during pregnancy. Materials and methods - the analysis of anonymous 
questioning within carrying out the second stage of the All-Russian pharmacoepidemiological 
research "Epidemiology of medicines use in pregnant women" which was carried out from February 
to April, 2015 The comparison of the received results with results of questioning of doctors of 
Belgorod region was executed on the basis of received data. Results and discussion. About a half of 
doctors chooses for heartburn treatment in pregnant women antacids medicines, and also inhibitors of 
a proton pomp (omeprazole). To 10% of doctors prescribe insufficiently studied blockers of H2-
histamine receptors. In constipation therapy more than 60% of doctors voted for salt laxative a 
lactulose. Less than 11% of doctors prescribed to patients unsafe medicines of senna and macrogol. 
Conclusion. The analysis of doctors’ answers on tactics of medicinal therapy purpose at heartburn and 
constipation during pregnancy has shown that more than 68% of the practicing experts appoint the 
therapy, based on rational use of medicines.  
Keywords: pregnancy, heartburn, constipation, lactulose, antacids medicines, inhibitors of a 
proton pomp, rational pharmacotherapy. 
 
Introduction: 
Digestive tract diseases – one of the most 
frequent pathologies which occur during pregnancy. 
The gastroesophageal reflux disease (GERD), 
especially one of its manifestations in the form of 
heartburn, takes the 2
nd
-3
rd
 place among all pathology 
of a gastrointestinal tract and reaches 20-80% (more 
often in pluripara women). Frequency of occurrence 
of a constipation is 50%-60% among pregnant [1, 2]. 
Important factors of development of a 
gastroesophageal reflux disease are: violation of 
motility of a food lump on a gullet and a stomach, and 
also aggression of components of gastric contents. In 
pregnant women to the main contributory cause it is 
necessary to refer increase of abdominal pressure and 
concentration of the progesterone in blood which 
influence on relaxation of the lower esophageal 
sphincter [3], and as a result, increase of frequency of 
the gastroesophageal refluxes leads to heartburn, 
gaseous or sour eructation, pains behind a breast [1, 4]. 
Heartburn is feeling of discomfort or burning 
behind a breast which extends from epigastric region 
up and leads to violation of a normal way of life [2, 
3, 5]. It can strengthen by body tilts, physical activity 
or horizontal position of a body after food. The 
heartburn occur at the first time during the gestation 
period meets so often that according to some 
information it is considered as a normal proceeding 
of pregnancy. However, the heartburn repeating more 
often than three times a week significantly reduces a 
quality of woman life. 
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The purpose of GERD treatment during the 
gestational period is the maximum use of agents of non-
drug therapy, especially in the first trimesters of 
pregnancy [1, 4, 6]. Such actions are referred to change 
of lifestyle of a pregnant woman and feeding behavior. 
After meal it is necessary to avoid the compelled 
position of a body at which heartburn appear or increase 
– forward inclination of body, horizontal position, 
physical activity with a strain of abdominal muscles, 
wearing of tight belt. During sleep it is better to raise the 
head extremity of a bed by 10-15 degrees 
Concerning a diet at heartburn and GERD it is 
necessary to adhere to fractional meal of small 
portions (to 6-7 times a day) [5, 6, 7, 8], to avoid 
products which irritate gastric mucosa and gullet – 
fried and spicy dishes, smoked products, row 
vegetables (especially which contain rough cellulose 
– a white cabbage, a garden radish, a radish, garlic), 
sour fruit and juice, carbonated drinks, black bread, 
chocolate, mushrooms. Optimum impact on a 
mucous membrane is exerted by steamed food or 
dishes made in oven, baked vegetables and fruit, low-
fat sort of meat or fish, milk, cream, cottage cheese. 
These products belong to "natural antacid". Such 
simple actions help to avoid purpose of medicaments 
therapy in 60%-70% of cases of heartburn occur. 
Also in some situations it is enough to drink several 
drinks of water of room temperature for prevention of 
an eructation or heartburn [7, 9]. 
However, when these methods become 
insufficiently, for improvement of quality of pregnant 
woman life it is necessary to use medical 
preparations [7, 9, 11]. Traditionally for symptoms of 
heartburn reduction three types of drugs are applied 
which influence variously on a heartburn 
pathogenesis – reduce hydrochloric acid production 
in a stomach (the inhibitors of a proton pomp (IPP) 
and H2-gistaminoblokers (H2-GB)) and neutralize 
already emitted hydrochloric acid (antacid drugs). 
IPP (omeprazole) (category B on medicines 
classification of Food and Drug Administration 
(FDA) of USA) and antacid drugs are referred to the 
resolved drugs during pregnancy as the least soak up 
in a systemic blood stream through a mucosa of an 
esophagus and a stomach [8, 12]. 
One more widespread pathology during 
pregnancy is constipation – a chronic delay of 
defecation with intestines depletion less than three 
times a week [13]. The constipation is followed by 
such feelings as feeling of incomplete intestines 
depletion, the dense and small quantity of fecal 
masses, discomfort in a stomach, nausea, a loss of 
appetite, the suppressed mood. Frequency of 
occurrence of constipation at women during a 
gestation is caused by influence of hormones, 
progesterone in particular, on contractive activity of a 
large intestine which leads to lowering of physical 
activity of a thick gut. Reduction of level of a motilin 
in the II-III trimester of pregnancy, mechanical 
impaction of a large intestine by increased uterus are 
also impact on constipation appearance [13, 14, 15]. 
Emergence of constipation leads to a microbial 
content of a thick gut, penetration of pathogenic flora 
into a vagina and to the ascending infection of a 
Belgorod Region. The delay of the dejection can 
lead to premature discharge of amniotic fluid, threat 
of termination of pregnancy, inflammatory diseases 
of a mucous membrane of a uterus [14, 15, 16]. 
That’s why it should be paid special attention to 
therapy of constipation during pregnancy. In most 
cases it turns out to cope with constipation during a 
gestation by non-drug ways– to increase physical 
activity, to diversify a diet with the rich fibers food 
(bran, dried apricots, prunes, lactic products, a white 
cabbage, beetroot, tomatoes, marrows) [13, 16]. It is 
necessary to limit the binding and locking products – 
white bread, strong black and green tea, coffee, 
chocolate, farinaceous dishes [15, 17]. 
When non-drug therapy becomes inefficient, it is 
necessary to resort to pharmaceutical medicines 
which are everywhere used during locks. The most 
effective, safe and reliable agent during a 
constipation in pregnant women is lactulose [16, 17, 
18]. Being osmosaline laxative, the lactulose works 
in distal department of a thick gut, increases osmotic 
pressure and by that promotes water inflow in a gut 
that leads to dejection softening [19, 20]. 
In view of prevalence of GERD and 
constipation, its social significance and influence on 
quality of pregnant women life, a large number of 
complications, it become relevant to carry out a 
pharmacoepidemiological survey with the purpose of 
detection of doctors’ preferences in choice of the 
main medicines of heartburn and constipation 
treatment in pregnant women. 
Work purpose: To analyse the choice of AMT of 
doctors of Belgorod region of heartburn and 
constipation treatment in pregnant women. To compare 
data with the results received as a result of questioning 
which was carried out from February to April, 2015 in 4 
federal districts of the Russian Federation – Central, 
Privolzhskom, Ural and Far-Eastern. 
Materials and methods: At the heart of this 
research is the method of anonymous questioning 
within carrying out the second stage of the All-Russian 
pharmacoepidemiological research "Epidemiology of 
medicines use in pregnant women" which was carried 
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out from February to April, 2015. In the All-Russian 
pharmacoepidemiological research (ARR) 1066 
questionnaires were analyzed from which 734 
obstetricians-gynecologists and 332 therapists [21, 22]. 
Across Belgorod Region (BR) in questioning 
have participated: 94 doctors (28,7% of stationary 
and 69,1% of a polyclinic profile, p<0, 01) from 
which 77 (81,9%) obstetricians-gynecologists,  
17 (18,1%) therapists (p<0,0001), with the general 
length of work less than 5 years - 21,3% of doctors, 
5-10 years – 26,6%, 10-20 years of work – 20,2% of 
doctors and more than 20 years – 26,6%. Questioning 
was carried out on the basis of women’s consultation 
clinic, policlinics and maternity home of Belgorod, 
and also in the central regional hospital. 
The data received as a result of poll were entered 
and processed by Microsoft Exel. 
Main part: 
For definition of doctors’ preferences at 
heartburn treatment the list of the most often used 
medicines was presented in the questionnaire: 
1. Antacids. 
2. H2- GB (ranitidine, famotidine). 
3. IPP (omeprazole). 
4. Other. 
5. Don’t prescribe. 
Based on clinical references, antacids as the main 
agent at heartburn treatment in pregnant women had 
been chosen by 73,4% of doctors of BR (77,9% of 
obstetricians-gynecologists and 52,9% of therapists,  
р =0,03) and 75,4% of doctors of ARR (р =0,664). 
Inhibitors of a proton pomp, omeprazole in 
particular, as the medicine of the second line applied 
in pregnant women, and belonging to the category B 
on FDA, had been chosen only by obstetricians-
gynecologists of BR (5,2%) and 6,7% of doctors of 
ARR (р =0,363). 
H2-GB (ranitidine, famotidine), which is not 
recommended for application for pregnant women 
because of the adverse influences on a condition of a 
fetus, had been chosen only by obstetricians-
gynecologists of BR (7,8%) and doctors of the All-
Russian research (6,2%), р =0,941. 
8,5% of doctors of BR (5,2% of obstetricians-
gynecologists and 23,5% of therapists, р =0,014) and 
15,7% of doctors of ARR (р =0,063) had decided to 
refuse from therapy prescribing to the patients. 
Comparison of tactics of heartburn treatment in 
pregnant women among doctors of BR and ARR is 
presented in Table. 
Table.  
Comparison of tactics of heartburn treatment in pregnant women among doctors of Belgorod Region and the 
All-Russian research. 
Note: IPP-inhibitors of a proton pomp, H2-GB – H2-gistaminoblokatory, BR – Belgorod region, ARR –All-Russian research, 
р – the Chi-square according to Pearson. 
 
For definition of doctors’ preferences at 
constipation treatment in women in the period of a 
gestation, the following possible answers have been 
offered: 
1. Lactulose. 
2. Senna preparations (Senna, Senade, 
Regulaks). 
3. Macrogol. 
Also such possible answers have been provided 
as "I don't prescribe" and "others", with an 
opportunity to enter the most preferred medicine. 
Lactulose, as the depletive which is most 
suitable for pregnant women (safe and effective), had 
been chosen by 68,1% of doctors of BR (67,5% of 
obstetricians-gynecologists and 70,6% of therapists, р 
=0,806) and 75,0% of doctors of ARR (р =0,144). 
Senna preparations, which are not recommended 
for application during pregnancy because of possible 
risks of termination of pregnancy or premature birth, 
development of a hyponatremia or hypokalemia, had 
been chosen by 7,5% of experts from BR (7,8% of 
obstetricians-gynecologists and 5,9% of therapists, р 
=0,786) and 8,6% of doctors of ARR (р =0,694. 
Macrogol, the effective but still insufficiently 
studied during pregnancy medicine, had been chosen 
by 6,4% of doctors of BR (6,5% of obstetricians-
gynecologists and 5,9% of therapists, р =0,926) and 
9,9% of doctors of ARR (р =0,262) [22]. 
7,5% of doctors of BR (3,9% of obstetricians 
and 23,5% of therapists, р =0,005) and 11,5% of 
doctors of ARR (р =0,228) had decided not to 
prescribe medicines at a constipation in pregnant 
women. 
Medicines 
Doctors of BR Doctors of  ARR  (n=1066), % 
р 
N=94 % N=1066 % 
Antacids 69 73,4 804 75,4 0,664 
IPP (omeprazole) 4 4,3 71 6,7 0,363 
H2- GB (ranitidine, famotidine) 6 7,8 66 6,2 0,941 
Don’t prescribe pharmacotherapy 8 8,5 167 15,7 0,063 
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Among the offered own options of treatment 
candles with glycerine (locally) were prevalent (6,4% of 
doctors of BR and 2,3% of doctors of ARR). It also 
should be noted the special option of constipation 
treatment during pregnancy by the medicine 
"Dyufaston" which was written in the questionnaires by 
2 obstetricians-gynecologists of BR. 
Comparison of tactics of constipation treatment 
in pregnant women among doctors of BR and ARR is 
presented in the Picture. 
 
 
 
Figure. Frequency of assignment of medicines in case of constipation in pregnant women among obstetricians-gynecologists 
and therapists of Belgorod region and the Russian Federation. 
 
Conclusion. 
According to the carried-out questioning, about a 
half of doctors of Belgorod region and the All-Russian 
research appoint rational pharmacotherapy at GERB 
treatment in pregnant women. Antacids as medicine of 
the first line have chosen more than a half of doctors of 
BR and ARR, р =0,664. Less than 10% of doctors of 
various profile have chosen IPP (р =0,363). 
Regardless of national clinical references, 
canons of a rational pharmacotherapy during 
pregnancy, doctors of BR and ARR (7,8% and 6,2% 
respectively) decided to prescribe to patients H2-GB 
which have low evidential base of use for women in 
the period of a gestation, therefore are potentially 
dangerous to a fetus. 
It is paid much attention to constipation 
treatment during pregnancy because of high 
frequency of occurrence of this pathology among 
women of the gestational period. Accurately 
implement clinical recommendations and assign salt 
laxatives, lactulose in particular, more than a half of 
doctors of Belgorod region and the All-Russian 
research, р =0,144. 
About 10% of doctors have chosen unsafe or 
isn't final researched in pregnant medicines macrogol 
and senna medicines. Also, among doctors of 
Belgorod region and the All-Russian research 
prevailed not really effective way of solving the 
problem of constipation – locally application of 
candles with glycerine, р =0,002. 
Corollary: 
According to questioning, more than 84% of 
obstetricians-gynecologists and therapists of 
Belgorod region and the All-Russian research 
conduct treatment of heartburn and constipations in 
pregnant women independently. The analysis of 
answers of doctors of BR and ARR on tactics of 
prescription of medicines showed that more than 68% 
of the practicing experts prescribe therapy, based on 
clinical references and a rational pharmacotherapy. 
Results of questioning showed once again relevance 
of a problem of adequate therapy of women during 
pregnancy at the accompanying pathology. 
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